E
T2 Biosystems, Inc. TTOO
$0.1275 -$0.0045-3.41%
Recommendation
Sell
Prev Close
$0.132
Volume
126,604
Avg Vol (90D)
1,269,547
Market Cap
$3.70M
Dividend & Yield
--
52-Week Range
$0.056 - $6.80
P/E (TTM)
--
EPS (TTM)
-$5.94
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Weak
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
T2 Biosystems Receives Delisting Notice from Nasdaq, Plans to Move to OTC MarketsLEXINGTON, Massachusetts-(BUSINESS WIRE)-T2 Biosystems, Inc. (NASDAQ: TTOO) announced today that it has received notice from the Nasdaq Stock Market LLC ("Nasdaq") reg
2/14/2025 - Ticker Report
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com
2/8/2025 - Ticker Report
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com
1/31/2025 - Ticker Report
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com
1/22/2025 - Ticker Report
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com
1/14/2025 - Ticker Report
T2 Biosystems reports preliminary Q4 revenue $2.3M
1/7/2025 - The Fly
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
1/7/2025 - GuruFocus
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
1/7/2025 - Globe Newswire
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com
1/6/2025 - Ticker Report
**T2 Biosystems Announces Amendments and Voting Results from Annual Meeting**Lexington, Massachusetts and#8211; T2 Biosystems, Inc. (NASDAQ: TTOO) recently disclosed significant updates from its recent Annual Meeting with stockholders held on December 30, 20
1/4/2025 - Ticker Report
T2 Biosystems Enhances Governance and Leadership Stability
1/3/2025 - TipRanks Financial Blog
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)
12/29/2024 - Ticker Report
T2 Biosystems (NASDAQ:TTOO) vs. Vasamed (OTCMKTS:VSMD) Head to Head Survey
12/25/2024 - Ticker Report
T2 Biosystems sells four T2Dx Instruments to European distributor
12/18/2024 - Seeking Alpha - Healthcare
T2 Biosystems sells four T2Dx Instruments to European distributor
12/18/2024 - SeekingAlpha.com: All News
T2 Biosystems announces sale of four T2Dx Intruments to European distributor
12/18/2024 - The Fly
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
12/18/2024 - Globe Newswire
T2 Biosystems achieves milestone with 250,000th novel sepsis test shipped
12/17/2024 - The Fly
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
12/17/2024 - GuruFocus
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
12/17/2024 - Globe Newswire
T2 Biosystems extends multi-year supplier agreement with Vizient
12/16/2024 - The Fly
T2 Biosystems announces extension of multi-year capital equipment supplier agreement with Vizient
12/16/2024 - SeekingAlpha.com: All News
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with ...
12/16/2024 - GuruFocus
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
12/16/2024 - Globe Newswire
**T2 Biosystems (NASDAQ:TTOO) Receives Delisting Notice from Nasdaq**Lexington, Massachusetts-based T2 Biosystems, Inc. (NASDAQ:TTOO) recently disclosed in an 8-K filing with the Securities and Exchange Commission (SEC) that it has received a notific
12/15/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
$7.68M
EBITDA (TTM)
-$41.40M
EBIT (TTM)
-$41.66M
Net Income (TTM)
-$42.95M
Balance Sheet
Total Assets (Q)
$18.08M
Total Debt (Q)
$18.94M
Total Liabilities (Q)
$29.79M
Book Value Per Share (Q)
-$0.6242
Cash Flow
Cash from Operations (TTM)
-$36.59M
Cash from Investing (TTM)
-$26.00K
Cash from Financing (TTM)
$14.38M
Net Change in Cash (TTM)
-$22.24M
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Beginning of April (est)
Price History
Loading...
Beta
-2.61
7-Day Total Return
-5.56%
30-Day Total Return
-44.57%
60-Day Total Return
-73.16%
90-Day Total Return
-86.83%
Year to Date Total Return
-68.13%
1-Year Total Return
-97.25%
2-Year Total Return
-99.78%
3-Year Total Return
-99.99%
5-Year Total Return
-99.99%
52-week Low
Feb 14, 2025 - $0.056
52-week High
Jun 24, 2024 - $6.80
Valuation
Market Cap
$3.70M - Nano Cap
Enterprise Value
$20.56M
Price/Sales (TTM)
0.31
Price/Book (Q)
-0.21
Dividends and Shares
Shares Outstanding
17.89M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.t2biosystems.com
Phone Number
781 761 4646
Address
101 Hartwell Avenue
Lexington, MA 02421
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of... more
OTC PK 03/12/2025 3:38PM Eastern Quotes delayed
Weiss Ratings